STOCK TITAN

Rockwell Medical (RMTI) director receives 9,633-share RSU award after reverse split

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Radie Robert S reported acquisition or exercise transactions in this Form 4 filing.

ROCKWELL MEDICAL, INC. director Robert S. Radie received an award of 9,633 shares of common stock as a grant of restricted stock units, with no cash paid per share. Following this grant, he beneficially owns 23,985 shares directly.

The restricted stock units vest on July 1, 2027, subject to his continued service through the company’s 2027 annual meeting. The company also implemented a 1-for-10 reverse stock split effective July 1, 2026, and Radie’s reported shareholdings and equity awards have been adjusted to reflect this split.

Positive

  • None.

Negative

  • None.
Insider Radie Robert S
Role null
Type Security Shares Price Value
Grant/Award Common Stock 9,633 $0.00 --
Holdings After Transaction: Common Stock — 23,985 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
RSU grant size 9,633 shares Restricted stock unit award on July 1, 2026
Grant price $0.00 per share Equity compensation, no cash paid
Post-transaction holdings 23,985 shares Common stock beneficially owned after grant
Reverse split ratio 1-for-10 Common stock reverse split effective July 1, 2026
Vesting date July 1, 2027 RSUs vesting subject to continued service
Restricted stock units financial
"Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
reverse split financial
"the Issuer effected a 1-for-10 reverse split of the Issuer's common stock"
A reverse split is when a company reduces the number of its outstanding shares by combining several existing shares into one new share, so the price per share rises proportionally while the company’s overall value stays the same. Investors care because it can make a stock appear more respectable or meet exchange rules — like turning many small coins into a single larger bill — but it can also signal financial trouble and often affects trading liquidity and investor perception.
beneficially owned financial
"Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
equity awards financial
"proportionate adjustments were made to the Issuer's outstanding equity awards"
Equity awards are payments to employees or directors made in the form of company stock or rights to buy stock later, serving as a way to share ownership rather than cash. For investors, they matter because they align staff incentives with company performance, can increase the number of shares outstanding over time (which can reduce each share’s claim on profits), and create compensation costs that affect reported earnings.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Radie Robert S

(Last)(First)(Middle)
C/O ROCKWELL MEDICAL, INC.
30142 WIXOM ROAD

(Street)
WIXOM MICHIGAN 48393

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A(1)9,633A$023,985(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted stock units vest on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through the 2027 Annual Meeting.
2. Effective at 12:01 AM on July 1, 2026, the Issuer effected a 1-for-10 reverse split of the Issuer's common stock resulting in a reduction in the number of shares held by the Reporting Person. In addition, proportionate adjustments were made to the Issuer's outstanding equity awards. Accordingly, the shares listed under Amount of Securities Beneficially Owned Following Reported Transaction(s) reported in this Form 4 have been adjusted to reflect the 1-for-10 reverse split.
Remarks:
/s/ Megan Timmins, Attorney-in-Fact for Robert S. Radie07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Rockwell Medical (RMTI) director Robert S. Radie report in this Form 4?

Robert S. Radie reported receiving 9,633 shares of Rockwell Medical common stock as a restricted stock unit grant. This is a compensation-related equity award at no cost per share, increasing his direct beneficial ownership to 23,985 shares.

What are the vesting terms of Robert Radie’s new Rockwell Medical (RMTI) restricted stock units?

The restricted stock units vest on July 1, 2027, if Robert S. Radie continues serving Rockwell Medical through the 2027 annual meeting. Until vesting, the award represents a right to receive shares rather than fully unrestricted stock.

How many Rockwell Medical (RMTI) shares does Robert Radie own after this Form 4 transaction?

After the reported grant, Robert S. Radie beneficially owns 23,985 shares of Rockwell Medical common stock directly. This figure reflects adjustments for the company’s 1-for-10 reverse stock split effective July 1, 2026.

Was there a reverse stock split mentioned in this Rockwell Medical (RMTI) Form 4?

Yes. Rockwell Medical effected a 1-for-10 reverse split of its common stock effective July 1, 2026. The number of shares held by Robert S. Radie and his outstanding equity awards were proportionately adjusted to reflect this reverse split.

Did Robert Radie buy or sell Rockwell Medical (RMTI) shares on the open market?

No open-market buy or sell was reported. The Form 4 shows a grant of 9,633 restricted stock units at a price of $0.00 per share, which is a compensation award rather than a market purchase or sale.